Letter to House re Immunocompromised Patients and COVID Funding
Citations
American Society of Hematology. (2022).
Letter to House re Immunocompromised Patients and COVID Funding.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/letter-to-house-re-immunocompromised-patients-and-covid-funding.
American Society of Hematology.
"Letter to House re Immunocompromised Patients and COVID Funding." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/letter-to-house-re-immunocompromised-patients-and-covid-funding
(label-accessed October 03, 2023).
"American Society of Hematology."
Letter to House re Immunocompromised Patients and COVID Funding, 03 Oct. 2023 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/letter-to-house-re-immunocompromised-patients-and-covid-funding.